Amexdrug Corp. Subsidiary BioRx to Unveil Several New Product Offerings
BEVERLY HILLS, CA--(Marketwire - July 08, 2009) -
Highlighted Links |
www.amexdrug.com |
According to Mr. Jack Amin, President of Amexdrug, "Each of these new products has passed several levels of rigorous testing and has been specifically designed to answer recognized needs in the marketplace. We are operating in a dynamic, multi-billion dollar industry that presents tremendous opportunities for growth, and we are extremely optimistic that these new products will only enhance our already strong product line. Likewise, we strongly believe that our new offerings will contribute to and enhance both increased sales revenues as well as stronger profit margins, and we look forward to providing additional details as we reach further milestones."
About Amexdrug Corporation:
Amexdrug Corporation is a vertically integrated company operating in the highly lucrative pharmaceutical and cosmeceutical industries. Along with its subsidiaries Dermagen, Inc. and BioRX Pharmaceuticals, Amexdrug is engaged in the research and development, marketing, production and sale of over-the-counter (OTC) pharmaceuticals and cosmetics as well as the distribution of prescription and over-the-counter drugs. The Company has advanced manufacturing facilities as well as an extensive distribution network, allowing Amexdrug to integrate various phases of operations into one efficient business entity. For more about Amexdrug, go to our website at www.amexdrug.com.